LA INDOMETACINA DA SOLA NON BASTA A PREVENIRE LA PANCREATITE DOPO ERCP: MEGLIO INSERIRE ANCHE UNA PROTESI. UN TRIAL DI NON-INFERIORITA’ AMERICANO DA “THE LANCET”
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial Prof B Joseph Elmunze et al. Summary Background The combination of rectally administered indomethacin and placement of a prophylactic pancreatic stent is recommended to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in high-risk patients. Preliminary evidence suggests that…

